<DOC>
	<DOCNO>NCT00998088</DOCNO>
	<brief_summary>Aim : investigate whether use several transfusion alternative ( erythropoietin , cell-saver postoperative drainage reinfusion system ) patient undergo elective total knee hip replacement surgery lead allogeneic red blood cell ( RBC ) save restrictive transfusion policy use . Study design : prospective , double randomize , open , multicenter study patient stratify accord preoperative hemoglobin ( Hb ) level : stratum I= Hb 6,1 8,2 mmol/l . These patient first randomize Erythropoetin ( Epo ) Epo . Stratum II= Hb 6,1 low 8,2 mmol/l high , eligible Epo thus randomize . Patients strata randomized three modality : cell saver ( CS ) ( wash , filter reinfuse autologous shed blood ) use intra- postoperatively postoperative autologous reinfusion drainage system ( D ) ( filter reinfuse autologous shed blood ) restrictive transfusion trigger ( control ) . Inclusion criterion : All orthopedic patient 18 year old consider primary revision total knee- ( TKR ) total hip replacement ( THR ) . Outcome measure : Primary outcome : number allogeneic red blood cell ( RBC ) transfusion . Secondary outcome : transfusion reaction , rehabilitation time , length hospital stay ( day ) , peri- post-operative complication hospitalization , quality life , cost analysis</brief_summary>
	<brief_title>Blood Management Orthopedic Surgery</brief_title>
	<detailed_description>Power/data analysis : In order able detect 75 % reduction allogeneic transfusion Epo reduction 30 % autologous ( shed blood ) transfusion ( CS D ) power= 0.9 alpha= 0.05 , inclusion 2250 surgery patient ( bad case scenario high standard deviation ) require intention-to-treat analysis . Knee surgery patient randomize cell saver ( intra-operative blood loss ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Orthopaedic patient 18 year old schedule primary revision total knee ( TKR ) total hip replacement ( THR ) . Patients refuse homologous blood ( e.g.Jehovah 's witness ) , Patients untreated hypertension ( diastolic blood pressure &gt; 95 mm Hg ) , Patients serious disorder coronary artery , peripheral artery and/or carotid artery , A recent myocardial infarction CVA , Sickle cell anaemia patient , Malignancy operate area , Pregnancy , Unsuitability perioperative anticoagulation prophylaxis , Known allergy erythropoietin , An infect wound bed , Revision infect prosthesis treat antibiotic , OR Patients difficulty understand Dutch language ( unable give inform consent patient insufficiently control Dutch language ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Blood management</keyword>
	<keyword>Orthopedic surgery</keyword>
	<keyword>elective</keyword>
	<keyword>randomize study</keyword>
	<keyword>adult</keyword>
	<keyword>hip replacement</keyword>
	<keyword>knee replacement</keyword>
</DOC>